These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 25526472)
1. XRCC2 promotes colorectal cancer cell growth, regulates cell cycle progression, and apoptosis. Xu K; Song X; Chen Z; Qin C; He Y; Zhan W Medicine (Baltimore); 2014 Dec; 93(28):e294. PubMed ID: 25526472 [TBL] [Abstract][Full Text] [Related]
2. XRCC2-Deficient Cells are Highly Sensitive to 5-Fluorouracil in Colorectal Cancer. Zhang YZ; An JH; Liu YX; Wu XC; Han SS; Ren XQ; Qin CJ Cell Physiol Biochem; 2017; 43(3):1207-1219. PubMed ID: 28977800 [TBL] [Abstract][Full Text] [Related]
3. UHRF1 promotes cell growth and metastasis through repression of p16(ink⁴a) in colorectal cancer. Wang F; Yang YZ; Shi CZ; Zhang P; Moyer MP; Zhang HZ; Zou Y; Qin HL Ann Surg Oncol; 2012 Aug; 19(8):2753-62. PubMed ID: 22219067 [TBL] [Abstract][Full Text] [Related]
4. PARP1 bound to XRCC2 promotes tumor progression in colorectal cancer. Xu K; Yu Z; Lu T; Peng W; Gong Y; Chen C Discov Oncol; 2024 Jun; 15(1):238. PubMed ID: 38907095 [TBL] [Abstract][Full Text] [Related]
5. XRCC2 rs3218536 polymorphism decreases the sensitivity of colorectal cancer cells to poly(ADP-ribose) polymerase 1 inhibitor. Xu K; Song X; Chen Z; Qin C; He Y Oncol Lett; 2014 Sep; 8(3):1222-1228. PubMed ID: 25120693 [TBL] [Abstract][Full Text] [Related]
6. PARP inhibitor olaparib enhances the efficacy of radiotherapy on XRCC2-deficient colorectal cancer cells. Qin C; Ji Z; Zhai E; Xu K; Zhang Y; Li Q; Jing H; Wang X; Song X Cell Death Dis; 2022 May; 13(5):505. PubMed ID: 35643812 [TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA FOXP4-AS1 is an unfavourable prognostic factor and regulates proliferation and apoptosis in colorectal cancer. Li J; Lian Y; Yan C; Cai Z; Ding J; Ma Z; Peng P; Wang K Cell Prolif; 2017 Feb; 50(1):. PubMed ID: 27790757 [TBL] [Abstract][Full Text] [Related]
8. Knockdown of GRHL3 inhibits activities and induces cell cycle arrest and apoptosis of human colorectal cancer cells. Wang XK; Zhou FF; Tao HR; Wang X; Zhang C; Su F; Wang SP; Xu LH; Pan XK; Feng MH; Xie W J Huazhong Univ Sci Technolog Med Sci; 2017 Dec; 37(6):880-885. PubMed ID: 29270747 [TBL] [Abstract][Full Text] [Related]
9. miR-7 inhibits colorectal cancer cell proliferation and induces apoptosis by targeting XRCC2. Xu K; Chen Z; Qin C; Song X Onco Targets Ther; 2014; 7():325-32. PubMed ID: 24570594 [TBL] [Abstract][Full Text] [Related]
10. ST13, a proliferation regulator, inhibits growth and migration of colorectal cancer cell lines. Bai R; Shi Z; Zhang JW; Li D; Zhu YL; Zheng S J Zhejiang Univ Sci B; 2012 Nov; 13(11):884-93. PubMed ID: 23125081 [TBL] [Abstract][Full Text] [Related]
11. IRF1 regulates the progression of colorectal cancer via interferon‑induced proteins. Xu X; Wu Y; Yi K; Hu Y; Ding W; Xing C Int J Mol Med; 2021 Jun; 47(6):. PubMed ID: 33907823 [TBL] [Abstract][Full Text] [Related]
12. Upregulation of miR-582-5p inhibits cell proliferation, cell cycle progression and invasion by targeting Rab27a in human colorectal carcinoma. Zhang X; Zhang Y; Yang J; Li S; Chen J Cancer Gene Ther; 2015 Oct; 22(10):475-80. PubMed ID: 26384136 [TBL] [Abstract][Full Text] [Related]
13. LncRNA CASC9 interacts with CPSF3 to regulate TGF-β signaling in colorectal cancer. Luo K; Geng J; Zhang Q; Xu Y; Zhou X; Huang Z; Shi KQ; Pan C; Wu J J Exp Clin Cancer Res; 2019 Jun; 38(1):249. PubMed ID: 31186036 [TBL] [Abstract][Full Text] [Related]
14. Up-regulation of REG3A in colorectal cancer cells confers proliferation and correlates with colorectal cancer risk. Ye Y; Xiao L; Wang SJ; Yue W; Yin QS; Sun MY; Xia W; Shao ZY; Zhang H Oncotarget; 2016 Jan; 7(4):3921-33. PubMed ID: 26646797 [TBL] [Abstract][Full Text] [Related]
15. [Role of allograft inflammatory factor-1 in regulating the proliferation, migration and apoptosis of colorectal cancer cells]. Ai XL; Yao F; Wang XJ; Duan DB; Li K; Hu ZY; Yin G; Wang M; Wu BY Nan Fang Yi Ke Da Xue Xue Bao; 2018 May; 38(5):511-519. PubMed ID: 29891445 [TBL] [Abstract][Full Text] [Related]
16. Long Non-Coding RNA Reprogramming (ROR) Promotes Cell Proliferation in Colorectal Cancer via Affecting P53. Li H; Jiang X; Niu X Med Sci Monit; 2017 Feb; 23():919-928. PubMed ID: 28216611 [TBL] [Abstract][Full Text] [Related]
17. LncRNA AB073614 regulates proliferation and metastasis of colorectal cancer cells via the PI3K/AKT signaling pathway. Wang Y; Kuang H; Xue J; Liao L; Yin F; Zhou X Biomed Pharmacother; 2017 Sep; 93():1230-1237. PubMed ID: 28738539 [TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA SNHG17 is an unfavourable prognostic factor and promotes cell proliferation by epigenetically silencing P57 in colorectal cancer. Ma Z; Gu S; Song M; Yan C; Hui B; Ji H; Wang J; Zhang J; Wang K; Zhao Q Mol Biosyst; 2017 Oct; 13(11):2350-2361. PubMed ID: 28933484 [TBL] [Abstract][Full Text] [Related]
19. Combined olaparib and oxaliplatin inhibits tumor proliferation and induces G2/M arrest and γ-H2AX foci formation in colorectal cancer. Xu K; Chen Z; Cui Y; Qin C; He Y; Song X Onco Targets Ther; 2015; 8():3047-54. PubMed ID: 26543375 [TBL] [Abstract][Full Text] [Related]
20. The long noncoding RNA HOXA transcript at the distal tip promotes colorectal cancer growth partially via silencing of p21 expression. Lian Y; Ding J; Zhang Z; Shi Y; Zhu Y; Li J; Peng P; Wang J; Fan Y; De W; Wang K Tumour Biol; 2016 Jun; 37(6):7431-40. PubMed ID: 26678886 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]